Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04674228 · ClinicalTrials.gov registry record
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
A clinical trial of Familial Adenomatous Polyposis, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 42
- Enrollment target
- 2
- Study locations
NCT04674228: Completed study of Familial Adenomatous Polyposis, sponsored by National Cancer Institute (NCI).
NCT04674228 is a study of Familial Adenomatous Polyposis that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 42 participants, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04674228, a study of Familial Adenomatous Polyposis, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyposis disease burden after discontinuation of weekly erlotinib.
Primary Outcome
Will be assessed by endoscopy.
Conditions Studied
Interventions
- OTHER Electronic Health Record Review
Study Locations (2)
Minnesota
- Mayo Clinic in Rochester - Rochester
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-07 |
| Est. Completion | 2022-05-17 |
What the finished NCT04674228 record still lists
NCT04674228 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Familial Adenomatous Polyposis appearing as the primary indexed condition, and to 1 intervention - of which Electronic Health Record Review is the first listed.
NCT04674228 reports a single indexed study location in Minnesota, Texas.
Frequently Asked Questions
What is clinical trial NCT04674228 about?
NCT04674228 is a clinical study titled "Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01". This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyp...
What is the current status of trial NCT04674228?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2021-05-07. Estimated completion is 2022-05-17.
What conditions does trial NCT04674228 study?
This clinical trial studies the following conditions: Familial Adenomatous Polyposis.
What interventions are being tested in trial NCT04674228?
The interventions under investigation include: Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04674228?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04674228 being conducted?
This trial has 2 study locations across Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Adenomatous Polyposis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04674228's enrollment target sits among peer trials
42 7th of 10 higher than 4 of 10 other Familial Adenomatous Polyposis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Familial Adenomatous Polyposis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
RECRUITING
-
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
RECRUITING
-
Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
RECRUITING · NA
-
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RECRUITING · Phase 1
-
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
RECRUITING · NA
-
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI